BMC Neurology

official impact factor 2.80
Search for
Advanced search
BMC Neurology
Tools
Share this article
Open Access Highly Access Email this article to a friend

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

Carsten Saft*, Thorsten Lauter, Peter H Kraus, Horst Przuntek and Juergen E Andrich

BMC Neurology 2006, 6:11 doi:10.1186/1471-2377-6-11

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.